Physician profile
Joel Beck
NPI 1366569584
$2,227.87
in general payments reported to CMS, 2019-2025
13 companies · $526 in 2025
The $526 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $103 · 2021: $109 · 2022: $81.66 · 2023: $185 · 2024: $715 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,426.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $485.24 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $296.18 | 2025 | |
| Allergan, INC. | $252.01 | 2019-2022 | |
| Abbvie INC. | $248.60 | 2023-2024 | |
| Merz North America, INC. | $242.80 | 2019-2023 | Xeomin |
| Musculoskeletal Transplant Foundation INC. | $183.23 | 2024 | |
| Tepha INC | $173.86 | 2019 | |
| Galderma Laboratories, L.P. | $170.35 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $57.89 | 2023 | Seglentis |
| Revance Therapeutics, INC. | $43.78 | 2025 | Daxxify |
| Sientra, INC. | $30.38 | 2020 | |
| Abbott Laboratories | $22.72 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.83 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.